Dupuytren's contracture: the hand's cords slowly pulling the fingers in

Last updated September 3, 2026.

Dupuytren's contracture is a thickening of the palm's fibrous tissue forming nodules and cords that slowly pull one or more fingers (the ring and little finger usually) into a bent position that cannot be straightened. It progresses over years, it is strongly hereditary (the northern-European, Viking-descended pattern: often family-wide), and it is treated when the bend interferes: with the needle division, the collagenase injection, or surgery, each with genuine trade-offs.

What does it look like?

The stages: a firm nodule or lump in the palm (sometimes tender early), the skin puckering or dimpling over it, then the cords (the rope-like bands under the skin running into the finger), and the slow bending: the finger curling toward the palm over months to years, until the tabletop test fails (the hand cannot lie flat). It is usually painless after the early nodule stage, the ring and little fingers are the ordinary targets, both hands are often involved, and the feet and elsewhere occasionally get cousins of it.

Why does it happen?

The palm's fascial layer overgrows and contracts: the genetics dominate (the strong family pattern in northern-European ancestry: genuinely hereditary, nothing you did), with the associates: age (rare before 40), male sex, smoking, alcohol, diabetes, and the vibration-tool decades. It is not caused by manual work in any simple way (the office workers get it too: the genes lead). The pace varies: some crawl for decades, some run in years, and the younger the onset, the more aggressive the course tends to be.

Find answers to your Dupuytren's contracture

Start a free AI doctor consult →

What are the treatments?

When is it urgent?

Dupuytren's is never an emergency and is clinic medicine at its most schedulable; the reasons to move the appointment sooner: the bend progressing fast (months, not years), the hand function genuinely going (the grip, the washing, the pockets), and the knuckle pads or the tender nodules bothering. The fixed, long-standing severe bend is harder to correct fully than the moderate one: the tabletop test failing is the sensible referral trigger. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.

What a Pymander AI doctor consult looks like

Do you have lumps or cords in your palm, or fingers that are bending toward the palm and cannot be fully straightened?
My little and ring fingers on my right hand are slowly bending into my palm and I can no longer lay my hand flat on a table. My father and grandfather had the same. I am 58.
Thanks for giving me all this information. Based on what you've said, this is Dupuytren's contracture: the slow bending of the little and ring fingers, the failed tabletop test, and the father-and-grandfather history (it is strongly hereditary, especially in northern-European families) make the diagnosis straightforward. The good news: it is painless in the main and very treatable, and the failed tabletop test is exactly the point where treatment becomes worthwhile: the options run from the needle division and the enzyme injection (clinic procedures, quick recovery) to the surgery for the bigger bends, and a hand surgeon's assessment maps which fits your fingers. It progresses slowly and there is no emergency, but correcting it is easier before the bend gets severe: the referral is genuinely worth making now rather than in another year. Here's your care note to share with your care team.
Care note
Dupuytren's contracture, tabletop test failed, strong family history
Fifty-eight-year-old: progressive flexion contracture of right little and ring fingers, failed tabletop test, father and grandfather affected (classic hereditary northern-European pattern): Dupuytren's contracture. Plan: hand-surgery referral (needle fasciotomy vs collagenase vs fasciectomy by cord anatomy and degree), no urgency but treat-while-moderate logic stated, diabetes and smoking and alcohol review (associates and progression factors), both-hands and feet check for the cousins. Recurrence rates discussed per option at the consult.
View care note →

Illustrative example, not a real member's messages.

Common questions

Is it hereditary? Will my children get it?

Strongly hereditary in the main: Dupuytren's runs down families in the northern-European (the Viking-descended) populations, the genetics are genuine (several genes implicated, dominant-ish inheritance with variable expression), and your father-and-grandfather history is the classic signature. The honest family answer: your children carry a genuinely raised likelihood (especially the sons: men get it more and earlier), but expression varies (some carriers show a few palm nodules in their sixties and nothing more), nothing can be done to prevent it (it is not lifestyle-caused: the smoking, alcohol, and diabetes associations are accelerants, not the root), and the useful advice is awareness: the palm-nodule and tabletop-test knowledge, and the treat-when-moderate rule. Your own course (treated well at the moderate stage) is the family education.

Why did this happen? I have never worked with my hands.

The genes, not the job: the manual-labor association is a myth that refuses to die (the office workers and the surgeons get Dupuytren's at the same family-driven rates), and the actual drivers: the inherited tendency above all, then age (rare before 40, commoner each decade after), male sex (more and earlier), the northern-European ancestry, and the accelerants (smoking, alcohol, diabetes, and possibly the decades of vibration tools). Nothing you did with your hands caused it, and nothing you stop doing now prevents the other hand or the progression: the condition is the palm's fascia following its genetic program. The treatable part is the contracture; the tendency is baked in, and that is why the family history is the strongest predictor and the recurrence after treatment is ordinary.

When should it be treated? Can I wait?

The tabletop test is the field rule: while the hand still lies flat (palm and fingers fully on the table), watching is legitimate (the nodules and cords without contracture need no treatment), and once it fails (the fingers can no longer flatten), the treatment becomes worthwhile, because the correction is easier and fuller at the moderate bend than at the severe (the long-fixed 90-degree fingers straighten less completely than the 30-degree ones). The other genuine triggers: the bend interfering with life (the washing, the shaking hands, the glove, the pocket), or the progression running fast. The waiting carries no danger (it never becomes untreatable), but it spends straightening potential: the moderate-stage referral is the sweet spot you are at now.

What is the difference between the needle, the enzyme, and the surgery?

The three genuine options, with the trade-offs worth understanding: the needle fasciotomy (the cord divided with a needle tip through the skin, in clinic: the quickest, no wound, the finger straighter immediately, but the recurrence is highest and it suits the well-defined cords), the collagenase injection (the enzyme dissolving the cord, straightened the next day: non-surgical, good results, the swelling-bruising fortnight, recurrence between the other two), and the fasciectomy surgery (the diseased tissue actually removed: the most complete and durable correction for the significant and multiple bends, at the cost of the operation, the weeks of splinting and hand therapy, and its own recurrence over the years). None cures the tendency (the recurrence rates are the honest conversation), and the hand surgeon's mapping of your cords picks the tool.

Will it come back after treatment?

Honestly, often yes, and the expectations are better set than dashed: Dupuytren's treatment corrects the contracture, not the tendency, and recurrence rates over five years are substantial (highest after the needle division, lowest after the full surgery, but present with everything), especially in the young-onset and strong-family-history patients (your father-and-grandfather pattern cuts both ways). The pragmatic frame most patients settle into: treat the bend when it matters, enjoy the straightened years, and re-treat if it returns (the needle and the enzyme are repeatable), with the surgery saved for the significant. The alternative (never treating because it might return) spends the hand's function in the meantime. Managed as a recurring condition with effective treatments, it is genuinely livable.

Does it affect anything beyond the fingers?

The hand is the main stage, with the known cousins worth a check: the knuckle pads (the firm lumps over the finger knuckles), the foot version (the plantar fibromas: the arch nodules, usually just noted), and in a minority of men the penile version (the fibrous plaques: worth mentioning at the appointment if present: treatable too, and the association is recognized). The hand-function impact is the ordinary question (the grip and the flat-hand tasks going as the bend progresses), and the rare aggressive kind (the young-onset, the bilateral, the knuckle-padded: the Dupuytren's diathesis patients) gets the closer follow-up for the genuinely progressive course. At your examination the both-hands-and-feet check is routine: the mapping tells the surgeon (and you) what the next decade looks like.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.

Free AI doctor, 24/7 by textStart a free AI doctor consult